Hemodialysis Vascular Grafts Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hemodialysis Vascular Grafts Market to 2027 - Global Analysis and Forecasts by Material (Polyester, Polytetrafluoroethylene, Polyurethane, and Biological Materials), End User (Hospitals, Clinics, and Others), and Geography

Report Code: TIPRE00003087 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Arteriovenous (AV) grafts refers to the type of access used in the process of hemodialysis. The hemodialysis vascular graft is usually placed in the arm, however can be placed in the leg if necessary. The blood-flow through the graft provides a systematic flow pattern and controlled flow rate that helps to deliver enough blood for an adequate hemodialysis treatment.

The hemodialysis vascular grafts market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of kidney/renal diseases, increasing adoption of biological grafts, and limited availability of kidney donors for patients suffering with chronic renal diseases. Moreover, cost-effective product innovation and high potential growth from the emerging nations offer opportunities in the growth of the global hemodialysis vascular grafts market.

The "Global Hemodialysis Vascular Grafts Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global hemodialysis vascular grafts market with detailed market segmentation by material, end user and geography. The global hemodialysis vascular grafts market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hemodialysis vascular grafts market players and offers key trends and opportunities in the market.

The global hemodialysis vascular grafts market is segmented on the basis of material and end user. Based on material, the hemodialysis vascular grafts market is segmented as polyester, polytetrafluoroethylene, polyurethane, and biological materials. Based on end user, the hemodialysis vascular grafts market is segmented as hospitals, clinics, and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemodialysis vascular grafts market based on material and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hemodialysis vascular grafts market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the hemodialysis vascular grafts market in the forecast period, due to the high healthcare expenditure and increasing number of patients suffering with chronic kidney diseases adopting biological and tissue engineered vascular grafts. On the other hand, Asia Pacific region is expected to be the fastest growing region owing to existence of a large patient pool likely to undergo hemodialysis procedures, increasing per capita expenditure, and crunch of kidney donors.

The report analyzes factors affecting hemodialysis vascular grafts market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemodialysis vascular grafts market in these regions.

The report also includes the profiles of key hemodialysis vascular grafts companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the hemodialysis vascular grafts market include, W. L. Gore & Associates, Inc., BD, TERUMO CORPORATION, LeMaitre Vascular, Inc., Getinge AB, VASCULAR GENESIS, InnAVasc Medical, Inc., CryoLife, Inc., Merit Medical Systems, and Proteon Therapeutics, Inc. among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Haemodialysis Vascular Grafts Market- By Material
1.3.2. Haemodialysis Vascular Grafts Market- By End User
1.3.3. Haemodialysis Vascular Grafts Market- By Region
1.3.3.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HAEMODIALYSIS VASCULAR GRAFTS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. HAEMODIALYSIS VASCULAR GRAFTS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HAEMODIALYSIS VASCULAR GRAFTS MARKET- GLOBAL ANALYSIS
6.1. HAEMODIALYSIS VASCULAR GRAFTS MARKET - GLOBAL MARKET OVERVIEW
6.2. HAEMODIALYSIS VASCULAR GRAFTS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. HAEMODIALYSIS VASCULAR GRAFTS MARKET REVENUE AND FORECASTS TO 2027 - MATERIAL
7.1. OVERVIEW
7.2. MATERIAL MARKET FORECASTS AND ANALYSIS
7.3. POLYESTER MARKET
7.3.1. Overview
7.3.2. Polyester Market Forecast and Analysis (US$ Mn)
7.4. POLYTETRAFLUOROETHYLENE MARKET
7.4.1. Overview
7.4.2. Polytetrafluoroethylene Market Forecast and Analysis (US$ Mn)
7.5. POLYRURETHANE MARKET
7.5.1. Overview
7.5.2. Polyrurethane Market Forecast and Analysis (US$ Mn)
7.6. BIOLOGICAL MATERIALS MARKET
7.6.1. Overview
7.6.2. Biological Materials Market Forecast and Analysis (US$ Mn)

8. HAEMODIALYSIS VASCULAR GRAFTS MARKET REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis (US$ Mn)
8.4. CLINICS MARKET
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis (US$ Mn)
8.5. OTHERS MARKET
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis (US$ Mn)

9. HAEMODIALYSIS VASCULAR GRAFTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA HAEMODIALYSIS VASCULAR GRAFTS MARKET
9.1.1. North America Haemodialysis Vascular Grafts Market Forecasts and Analysis (US$ Mn)
9.1.2. North America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.1.3. North America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.1.4. North America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Country
9.1.5. US Market Overview
9.1.5.1. US Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.1.5.2. US Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.1.6. Canada Market Overview
9.1.6.1. Canada Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.1.6.2. Canada Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.1.7. Mexico Market Overview
9.1.7.1. Mexico Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.1.7.2. Mexico Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2. EUROPE HAEMODIALYSIS VASCULAR GRAFTS MARKET
9.2.1. Europe Haemodialysis Vascular Grafts Market Forecasts and Analysis (US$ Mn)
9.2.2. Europe Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.3. Europe Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2.4. Europe Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Country
9.2.5. UK Market Overview
9.2.5.1. UK Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.5.2. UK Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2.6. Germany Market Overview
9.2.6.1. Germany Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.6.2. Germany Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2.7. France Market Overview
9.2.7.1. France Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.7.2. France Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2.8. Italy Market Overview
9.2.8.1. Italy Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.8.2. Italy Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.2.9. Spain Market Overview
9.2.9.1. Spain Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.2.9.2. Spain Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3. ASIA PACIFIC HAEMODIALYSIS VASCULAR GRAFTS MARKET
9.3.1. Asia Pacific Haemodialysis Vascular Grafts Market Forecasts and Analysis (US$ Mn)
9.3.2. Asia Pacific Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.3. Asia Pacific Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3.4. Asia Pacific Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Country
9.3.5. China Market Overview
9.3.5.1. China Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.5.2. China Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3.6. Japan Market Overview
9.3.6.1. Japan Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.6.2. Japan Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3.7. India Market Overview
9.3.7.1. India Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.7.2. India Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3.8. Australia Market Overview
9.3.8.1. Australia Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.8.2. Australia Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.3.9. South Korea Market Overview
9.3.9.1. South Korea Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.3.9.2. South Korea Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.4. MIDDLE EAST AND AFRICA (MEA) HAEMODIALYSIS VASCULAR GRAFTS MARKET
9.4.1. Middle East and Africa (MEA) Haemodialysis Vascular Grafts Market Forecasts and Analysis (US$ Mn)
9.4.2. Middle East and Africa (MEA) Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.4.3. Middle East and Africa (MEA) Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.4.4. Middle East and Africa (MEA) Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Country
9.4.5. UAE Market Overview
9.4.5.1. UAE Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.4.5.2. UAE Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.4.6. Saudi Arabia Market Overview
9.4.6.1. Saudi Arabia Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.4.6.2. Saudi Arabia Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.4.7. South Africa Market Overview
9.4.7.1. South Africa Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.4.7.2. South Africa Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.5. SOUTH AND CENTRAL AMERICA HAEMODIALYSIS VASCULAR GRAFTS MARKET
9.5.1. South and Central America Haemodialysis Vascular Grafts Market Forecasts and Analysis (US$ Mn)
9.5.2. South and Central America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.5.3. South and Central America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.5.4. South and Central America Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Country
9.5.5. Brazil Market Overview
9.5.5.1. Brazil Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.5.5.2. Brazil Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)
9.5.6. Argentina Market Overview
9.5.6.1. Argentina Haemodialysis Vascular Grafts Market Forecasts and Analysis - By Material (US$ Mn)
9.5.6.2. Argentina Haemodialysis Vascular Grafts Market Forecasts and Analysis - By End User (US$ Mn)

10. INDUSTRY LANDSCAPE
10.1. ORGANIC GROWTH STRATEGIES
10.1.1. New Product Launches
10.1.2. Marketing & Promotional Activities
10.2. INORGANIC GROWTH STRATEGIES
10.2.1. Partnerships, Collaborations, and Joint Ventures
10.2.2. Mergers & Acquisitions

11. HAEMODIALYSIS VASCULAR GRAFTS MARKET, KEY COMPANY PROFILES
11.1. W. L. GORE & ASSOCIATES, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TERUMO CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LEMAITRE VASCULAR, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GETINGE AB
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. VASCULAR GENESIS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. INNAVASC MEDICAL, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CRYOLIFE, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERIT MEDICAL SYSTEMS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PROTEON THERAPEUTICS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
?
The List of Companies

1. W. L. Gore & Associates, Inc.
2. BD
3. TERUMO CORPORATION
4. LeMaitre Vascular, Inc.
5. Getinge AB
6. VASCULAR GENESIS
7. InnAVasc Medical, Inc.
8. CryoLife, Inc.
9. Merit Medical Systems
10. Proteon Therapeutics, Inc.